Maternal-fetal deprivation and the cardiometabolic syndrome

Michael Bursztyn1, Ilana Ariel

  • 1Departments of Medicine, Hypertension Unit, and Pathology, Hadassah-Hebrew University Medical Center, Mount Scopus, Jerusalem, Israel. bursz@cc.huji.ac.il

Insights

Low birth weight may program the body for cardiometabolic syndrome, including obesity and diabetes, due to fetal adaptations to nutrient scarcity. This review explores the mechanisms behind this "fetal programming" and its long-term health consequences.

Area of Science:

  • Developmental biology
  • Cardiovascular science
  • Metabolic health

Background:

  • Epidemiologic studies link low birth weight to adverse cardiovascular outcomes.
  • Risk factors for cardiometabolic syndrome (obesity, insulin resistance, diabetes, hypertension) are associated with low birth weight.
  • Animal studies support the link between low birth weight and cardiometabolic syndrome.

Purpose of the Study:

  • To review adaptive responses in intrauterine growth restriction models.
  • To discuss mechanisms of fetal programming for cardiometabolic syndrome.
  • To explore the link between early-life nutrition and later-life metabolic health.

Main Methods:

  • Review of animal studies on intrauterine growth restriction.
  • Analysis of cellular and physiological adaptations to nutrient scarcity.
  • Examination of mechanisms mediating fetal programming.

Main Results:

  • Fetal programming involves adaptive responses to nutrient shortage during gestation.
  • These adaptations can lead to maladaptation when exposed to abundant nutrients postnatally.
  • Multifactorial mechanisms link low birth weight to later-life cardiometabolic syndrome.

Conclusions:

  • Fetal programming is a key mechanism linking low birth weight to cardiometabolic syndrome.
  • Understanding these mechanisms is crucial for preventing cardiovascular and metabolic diseases.
  • Early-life environment significantly influences long-term health outcomes.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...